Breast Cancer

Breast cancer treatment delays can lead to a higher mortality rate and more expenses.

Experts predict that from 2024 to 2032, the breast cancer market will grow at a CAGR of 7.09%.

If approved by the FDA they would join Trodelvy as a treatment for triple-negative breast cancer.

The authors say their findings should not change women’s calculations about double, or bilateral mastectomy, which physicians generally discourage.

New research expands on previous knowledge that breast cancer survivors are more at risk for depression than people without breast cancer.

American Indian and Alaska Native women also had higher comorbidities and less access to private insurance than White women.

Grandmother and great-grandmother Donna Osborne had recently finished radiation therapy when she won the prize.

: A Taiwanese study builds upon previous contradictory research exploring the link between breast cancer and acute myocardial infarction.

Previous acupuncture studies have focused on European and American women, but little was known about breast cancer patients in Asia.

The same is not true for Black women, who are 40% more likely to die from breast cancer than white women, suggesting other factors are to blame.

Study results may change the understanding and treatment of hormone-based treatment of primary ovarian insufficiency based on genetics.

Wrong diagnoses were also made in women with dense, fatty breasts.

Breast cancer stats from the American Association for Cancer Research 2024 Cancer Disparities Report.

The update was prompted by a recent increase in breast cancer cases among women in their 40s.

Lack of health insurance and not having a healthcare provider are two of the biggest factors that contribute to skipping a mammogram.

Breast cancer predictions for this year.

Genes may help identify which cases of ductal carcinoma in situ are most likely to become invasive breast cancer.